Lewis Roca Rothgerber Christie announced that Diane Hazel has joined the firm’s Denver office as an associate in its litigation practice group.
Hazel represents companies in business litigation, class actions and government investigations. She assists clients with risk management and dispute resolution in a range of industries including insurance, energy, retail and industrial products, pharmaceuticals and health care. Hazel specializes in antitrust litigation and counseling and has worked on a variety of antitrust matters, including market allocation, price fixing, group boycotts and reverse payments.
Prior to joining Lewis Roca Rothgerber Christie, Hazel was with Hunton & Williams in Washington, DC. She was also an attorney in the Bureau of Competition at the Federal Trade Commission, where she investigated and prosecuted antitrust matters in the health care and pharmaceutical industries. During her tenure at FTC, she was awarded a Fulbright Grant from the U.S. State Department and spent a year in Namibia working with the Namibian government on antitrust and consumer protection matters.
Full content: PR Web
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas